Before chemotherapy, methylation frequencies of APC and/or RASSF1A were 48.9 % (46/94) in adenocarcinoma, 50.0 % (28/56) in squamous carcinoma, and 39.4 % (26/66) in other histological types. The gene discussed is RASSF1; the disease is adenocarcinoma.